TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
IMNM

Immunome Inc

Healthcare · Biotechnology

24.00$ +0.2% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet IMNM
Line item 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
47.5% 61.7% 96.3% 97.8% 94.2% 97.4% 92.1% 96.7%
36.0% 50.3% 89.3% 85.0% 84.5% 66.4% 59.7% 95.7%
36.0% 50.3% 89.3% 85.0% 84.5% 93.0% 90.5% 95.7%
1.9% 7.4% 3.5% 0.2%
-2.0% -7.4% -3.5%
46.8% 33.6% 3.4% 1.5% 2.8%
666.7% 804.2% 7.1% 16.8% 30.7% 19.3% 24.6% 7.1%
35.1% 32.9% 6.8% 16.8% 30.5% 14.7% 22.6% 6.6%
13.8% 8.9% 1.1% 0.5% 1.0% 0.2% 0.0%
10.6% 10.8% 2.7% 5.3% 10.0% 2.2% 5.9% 0.5%
7.3% 2.2% 0.3%
-566.7% -704.2% 92.9% 83.2% 69.3% 80.7% 75.4% 92.9%
-587.1% -722.5% -122.2% -136.6% -482.4% -150.0% -214.7% -106.6%
24.6% 113.5% 22.7% 19.9% 50.4% 13.4% 24.4% 12.8%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?